---
audienceLevel: patient
cancerTypes:
- lung
- liver
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Tremelimumab-actl - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/tremelimumab-actl
version: v1
---

# Tremelimumab-actl - NCI

# Tremelimumab-actl

Placeholder slot

(treh-meh-LIM-yoo-mab)

This page contains brief information about tremelimumab-actl
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Imjudo

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6690679c-be2f-4588-a2e4-89fff74dd6be&audience=consumer)

## Use in Cancer

Tremelimumab-actl
is approved to treat adults with:

- **[Hepatocellular carcinoma](/Common/PopUps/popDefinition.aspx?id=46363&version=Patient&language=English)** (a type of liver cancer) that cannot be removed by surgery. It is used with [durvalumab](/Common/PopUps/popDefinition.aspx?id=788775&version=Patient&language=English).
- **[Non-small cell lung cancer](/Common/PopUps/popDefinition.aspx?id=45323&version=Patient&language=English)** that has spread to other parts of the body and does not have an abnormal *[EGFR](/Common/PopUps/popDefinition.aspx?id=796876&version=Patient&language=English)* or *[ALK](/Common/PopUps/popDefinition.aspx?id=721252&version=Patient&language=English)* gene. It is used with durvalumab and platinum-based chemotherapy.

Tremelimumab-actl
is also being studied in the treatment of other types of
cancer.

## More About Tremelimumab-actl

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/448620) - Detailed scientific definition and other names for this drug.

## Research Results and Related Resources

[Study Identifies a Potential Cause of Immunotherapyâ€™s Heart-Related Side Effects](https://www.cancer.gov/news-events/cancer-currents-blog/2022/immunotherapy-myocarditis-cause)

[Targeted Cancer Therapies](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet)

[Immune Checkpoint Inhibitors](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors)

[Monoclonal Antibodies](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Tremelimumab-actl](https://www.cancer.gov/research/participate/clinical-trials/intervention/C49085) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
